Market outlook of the vitamin D testing market in the US
Market research analyst has estimated this market to show steady growth during the forecast period. The prospect for growth in this market is dependent on factors like the high incidence of vitamin D deficiency among the populace in this region, which results in its slow but moderate CAGR of around 4% by 2019.
To Download Sample Report With TOC@ http://www.researchmoz.us/enquiry.php?type=S&repid=499773
The prevention of various acute and chronic diseases is the key driver for the growth of this market. Vitamin D deficiency can lead to various chronic diseases like rickets and osteoporosis, and can also result in cardiovascular diseases, cancer, asthma in infants, cognitive disorders, and autoimmune diseases. The incidence of these diseases can be reduced by frequently testing the vitamin D levels, which in turn would help to reduce the overall healthcare expenditure.
Application-based segmentation and analysis of - 25-Hydroxy vitamin D tests & 1,25-Dihydroxy vitamin D test
In this market research report, analysts estimate the 25-Hydroxy vitamin D tests segment to be the largest market segment during the forecast period. Currently, this market segment accounts for a share of nearly 76% and is envisaged to retain its dominating hold over the market by 2019. The ability of 25-Hydroxy vitamin D tests to identify bone malformations and softness, bone weakness, or fractures in adults is one of the most significant factors that accounts for its high market share during the forecast period.
The report offers an analysis of each of the following segments and discusses its impact on the overall market growth -
25-Hydroxy vitamin D tests
1,25-Dihydroxy vitamin D test
Competitive landscape and key vendors - Roche Diagnostics, Abbott Diagnostics
This market is highly competitive and consists of vendors that focus on test development and research. These vendors compete on the basis of price,...